- Home
- AMLX vs SSII Comparison
AMLX vs SSII Comparison
Compare AMLX & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | SSII |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | SSII |
|---|---|---|
| Price | $13.98 | $3.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.43 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 112.0K |
| Earning Date | 03-03-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $36,066,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 158.36 |
| 52 Week Low | $2.60 | $3.02 |
| 52 Week High | $17.49 | $22.42 |
Technical Indicators
Market Signals| Indicator | AMLX | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 29.30 |
| Support Level | $12.94 | $3.40 |
| Resistance Level | $15.53 | $6.01 |
| Average True Range (ATR) | 1.11 | 0.52 |
| MACD | -0.23 | -0.15 |
| Stochastic Oscillator | 16.37 | 11.46 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.